In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis

Background: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or...

Full description

Autores:
Legarda-Ceballos A.L.
López-Abán J.
Del Olmo E.
Escarcena R.
Bustos L.A.
Rojas Caraballo, Jose Vicente
Vicente B.
Fernández-Soto P.
San Feliciano A.
Muro A.
Tipo de recurso:
Article of journal
Fecha de publicación:
2016
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/41843
Acceso en línea:
https://doi.org/10.16967/rpe.v4n2a3
http://revia.areandina.edu.co/ojs/index.php/IA/article/view/646
https://hdl.handle.net/20.500.12494/41843
Palabra clave:
1,2 alkanediamine derivative
2 aminoalkanol
antinematodal agent
edelfosine
ivermectin
unclassified drug
[2 (butylamino)hexadecan 1 ol]
[2 (ethylamino)hexadecan 1 ol]
[tert butyl n (1 aminododecan 2 yl)carbamate]
[tert butyl n (1 aminohexadecan 2 yl)carbamate]
aminoalcohol
anthelmintic agent
diamine
animal cell
animal experiment
animal model
animal tissue
Article
controlled study
cytotoxicity test
drug efficacy
drug identification
drug screening
drug structure
feces analysis
female
in vitro study
in vivo study
LC50
male
mouse
nonhuman
outcome assessment
rat
Strongyloides venezuelensis
strongyloidiasis
structure activity relation
XTT assay
animal
chemical structure
chemistry
drug effects
parasitology
Strongyloides
Amino Alcohols
Animals
Anthelmintics
Diamines
Male
Mice
Molecular Structure
Rats
Strongyloides
Strongyloidiasis
Structure-Activity Relationship
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
id COOPER2_baee5bc9aa91754a0c5595a9ce44adcc
oai_identifier_str oai:repository.ucc.edu.co:20.500.12494/41843
network_acronym_str COOPER2
network_name_str Repositorio UCC
repository_id_str
dc.title.spa.fl_str_mv In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
spellingShingle In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
1,2 alkanediamine derivative
2 aminoalkanol
antinematodal agent
edelfosine
ivermectin
unclassified drug
[2 (butylamino)hexadecan 1 ol]
[2 (ethylamino)hexadecan 1 ol]
[tert butyl n (1 aminododecan 2 yl)carbamate]
[tert butyl n (1 aminohexadecan 2 yl)carbamate]
aminoalcohol
anthelmintic agent
diamine
animal cell
animal experiment
animal model
animal tissue
Article
controlled study
cytotoxicity test
drug efficacy
drug identification
drug screening
drug structure
feces analysis
female
in vitro study
in vivo study
LC50
male
mouse
nonhuman
outcome assessment
rat
Strongyloides venezuelensis
strongyloidiasis
structure activity relation
XTT assay
animal
chemical structure
chemistry
drug effects
parasitology
Strongyloides
Amino Alcohols
Animals
Anthelmintics
Diamines
Male
Mice
Molecular Structure
Rats
Strongyloides
Strongyloidiasis
Structure-Activity Relationship
title_short In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_full In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_fullStr In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_full_unstemmed In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
title_sort In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
dc.creator.fl_str_mv Legarda-Ceballos A.L.
López-Abán J.
Del Olmo E.
Escarcena R.
Bustos L.A.
Rojas Caraballo, Jose Vicente
Vicente B.
Fernández-Soto P.
San Feliciano A.
Muro A.
dc.contributor.author.none.fl_str_mv Legarda-Ceballos A.L.
López-Abán J.
Del Olmo E.
Escarcena R.
Bustos L.A.
Rojas Caraballo, Jose Vicente
Vicente B.
Fernández-Soto P.
San Feliciano A.
Muro A.
dc.subject.spa.fl_str_mv 1,2 alkanediamine derivative
2 aminoalkanol
antinematodal agent
edelfosine
ivermectin
unclassified drug
[2 (butylamino)hexadecan 1 ol]
[2 (ethylamino)hexadecan 1 ol]
[tert butyl n (1 aminododecan 2 yl)carbamate]
[tert butyl n (1 aminohexadecan 2 yl)carbamate]
aminoalcohol
anthelmintic agent
diamine
animal cell
animal experiment
animal model
animal tissue
Article
controlled study
cytotoxicity test
drug efficacy
drug identification
drug screening
drug structure
feces analysis
female
in vitro study
in vivo study
LC50
male
mouse
nonhuman
outcome assessment
rat
Strongyloides venezuelensis
strongyloidiasis
structure activity relation
XTT assay
animal
chemical structure
chemistry
drug effects
parasitology
Strongyloides
Amino Alcohols
Animals
Anthelmintics
Diamines
Male
Mice
Molecular Structure
Rats
Strongyloides
Strongyloidiasis
Structure-Activity Relationship
topic 1,2 alkanediamine derivative
2 aminoalkanol
antinematodal agent
edelfosine
ivermectin
unclassified drug
[2 (butylamino)hexadecan 1 ol]
[2 (ethylamino)hexadecan 1 ol]
[tert butyl n (1 aminododecan 2 yl)carbamate]
[tert butyl n (1 aminohexadecan 2 yl)carbamate]
aminoalcohol
anthelmintic agent
diamine
animal cell
animal experiment
animal model
animal tissue
Article
controlled study
cytotoxicity test
drug efficacy
drug identification
drug screening
drug structure
feces analysis
female
in vitro study
in vivo study
LC50
male
mouse
nonhuman
outcome assessment
rat
Strongyloides venezuelensis
strongyloidiasis
structure activity relation
XTT assay
animal
chemical structure
chemistry
drug effects
parasitology
Strongyloides
Amino Alcohols
Animals
Anthelmintics
Diamines
Male
Mice
Molecular Structure
Rats
Strongyloides
Strongyloidiasis
Structure-Activity Relationship
description Background: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. Methods: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 µM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. Results: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9-39.1 µM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). Conclusions: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis. © 2016 The Author(s).
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.accessioned.none.fl_str_mv 2021-12-16T22:15:50Z
dc.date.available.none.fl_str_mv 2021-12-16T22:15:50Z
dc.type.none.fl_str_mv Artículo
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.16967/rpe.v4n2a3
http://revia.areandina.edu.co/ojs/index.php/IA/article/view/646
dc.identifier.issn.spa.fl_str_mv 17563305
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12494/41843
dc.identifier.bibliographicCitation.spa.fl_str_mv Legarda AL,López J,Del Olmo E,Escarcena R,Bustos LA,Rojas J,Vicente B,Fernández P,San Feliciano A,Muro A. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Parasit Vectors. 2016. 9. (1):p. 364-364. .
url https://doi.org/10.16967/rpe.v4n2a3
http://revia.areandina.edu.co/ojs/index.php/IA/article/view/646
https://hdl.handle.net/20.500.12494/41843
identifier_str_mv 17563305
Legarda AL,López J,Del Olmo E,Escarcena R,Bustos LA,Rojas J,Vicente B,Fernández P,San Feliciano A,Muro A. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Parasit Vectors. 2016. 9. (1):p. 364-364. .
dc.relation.ispartofjournal.spa.fl_str_mv PARASITE VECTOR
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_14cb
dc.format.extent.spa.fl_str_mv 364-364
dc.publisher.spa.fl_str_mv BioMed Central Ltd.
institution Universidad Cooperativa de Colombia
repository.name.fl_str_mv Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1814246747505950720
spelling Legarda-Ceballos A.L.López-Abán J.Del Olmo E.Escarcena R.Bustos L.A.Rojas Caraballo, Jose VicenteVicente B.Fernández-Soto P.San Feliciano A.Muro A.2021-12-16T22:15:50Z2021-12-16T22:15:50Z2016https://doi.org/10.16967/rpe.v4n2a3http://revia.areandina.edu.co/ojs/index.php/IA/article/view/64617563305https://hdl.handle.net/20.500.12494/41843Legarda AL,López J,Del Olmo E,Escarcena R,Bustos LA,Rojas J,Vicente B,Fernández P,San Feliciano A,Muro A. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Parasit Vectors. 2016. 9. (1):p. 364-364. .Background: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. Methods: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 µM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. Results: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9-39.1 µM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). Conclusions: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis. © 2016 The Author(s).josev.rojas@campusucc.edu.co364-364BioMed Central Ltd.1,2 alkanediamine derivative2 aminoalkanolantinematodal agentedelfosineivermectinunclassified drug[2 (butylamino)hexadecan 1 ol][2 (ethylamino)hexadecan 1 ol][tert butyl n (1 aminododecan 2 yl)carbamate][tert butyl n (1 aminohexadecan 2 yl)carbamate]aminoalcoholanthelmintic agentdiamineanimal cellanimal experimentanimal modelanimal tissueArticlecontrolled studycytotoxicity testdrug efficacydrug identificationdrug screeningdrug structurefeces analysisfemalein vitro studyin vivo studyLC50malemousenonhumanoutcome assessmentratStrongyloides venezuelensisstrongyloidiasisstructure activity relationXTT assayanimalchemical structurechemistrydrug effectsparasitologyStrongyloidesAmino AlcoholsAnimalsAnthelminticsDiaminesMaleMiceMolecular StructureRatsStrongyloidesStrongyloidiasisStructure-Activity RelationshipIn vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensisArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionPARASITE VECTORinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublication20.500.12494/41843oai:repository.ucc.edu.co:20.500.12494/418432024-08-20 16:17:20.358metadata.onlyhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.com